2016
The clinical and molecular epidemiology of pre‐transplant vancomycin‐resistant enterococci colonization among liver transplant recipients
Banach DB, Peaper DR, Fortune BE, Emre S, Dembry LM. The clinical and molecular epidemiology of pre‐transplant vancomycin‐resistant enterococci colonization among liver transplant recipients. Clinical Transplantation 2016, 30: 306-311. PMID: 26780305, DOI: 10.1111/ctr.12690.Peer-Reviewed Original ResearchConceptsLiver transplant recipientsLiver transplantationVRE colonizationTransplant recipientsVancomycin-resistant enterococci (VRE) infectionPolymerase chain reaction testingVancomycin-resistant enterococci colonizationPre-transplant colonizationSubsequent liver transplantationMore hospital daysObservational cohort studyCentral venous catheterizationInfection prevention measuresWarrants further studyRifaximin useAntimicrobial prophylaxisCohort studyHospital daysSignificant morbidityVenous catheterizationProspective studyActive surveillanceRisk factorsSurveillance culturesVRE isolates
2006
Life-Threatening Sepsis Caused by Burkholderia cepacia From Contaminated Intravenous Flush Solutions Prepared by a Compounding Pharmacy in Another State
Held MR, Begier EM, Beardsley DS, Browne FA, Martinello RA, Baltimore RS, McDonald LC, Jensen B, Hadler JL, Dembry LM. Life-Threatening Sepsis Caused by Burkholderia cepacia From Contaminated Intravenous Flush Solutions Prepared by a Compounding Pharmacy in Another State. Pediatrics 2006, 118: e212-e215. PMID: 16785290, DOI: 10.1542/peds.2005-2617.Peer-Reviewed Original ResearchConceptsBlood culturesOutside health care facilityBurkholderia cepacia sepsisLife-threatening casesLife-threatening sepsisPatient's blood culturesHealth care facilitiesInfusate contaminationPulsed-field gel electrophoresisFlush solutionCare facilitiesSafe deliverySepsisCompounding pharmaciesBacterial isolatesBurkholderia cepaciaMedicationsPatientsInfusate
1998
Molecular Analysis of Glycopeptide-ResistantEnterococcus faecium Isolates Collected from Michigan Hospitals over a 6-Year Period
Thal L, Donabedian S, Robinson-Dunn B, Chow J, Dembry L, Clewell D, Alshab D, Zervos M. Molecular Analysis of Glycopeptide-ResistantEnterococcus faecium Isolates Collected from Michigan Hospitals over a 6-Year Period. Journal Of Clinical Microbiology 1998, 36: 3303-3308. PMID: 9774583, PMCID: PMC105319, DOI: 10.1128/jcm.36.11.3303-3308.1998.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Bacterial AgentsBacterial Typing TechniquesChromosomes, BacterialCross InfectionDNA, BacterialDrug Resistance, MicrobialElectrophoresis, Gel, Pulsed-FieldEnterococcus faeciumGene Transfer TechniquesGenes, BacterialGram-Positive Bacterial InfectionsHumansMichiganMolecular EpidemiologyNucleic Acid HybridizationPlasmidsVancomycinConceptsExtended-care facilityPulsed-field gel electrophoresisEnterococcus faecium isolatesFaecium isolatesClonal disseminationVancomycin-resistant E. faeciumStrain typesE. faecium isolatesVancomycin-resistant E. faecium isolatesIntrahospital disseminationSpread of resistanceMichigan hospitalsMajority of isolatesPatientsHospitalClinical isolatesGentamicin resistanceVanA geneErythromycin resistanceE. faeciumVancomycin resistanceType M2VanB genesMolecular relatednessMost isolates
1997
In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
Dembry LM, Farrel PA, Orcutt DR, Gerrity LA, Andriole VT. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest. Journal Of Antimicrobial Chemotherapy 1997, 39: 35-42. PMID: 9222068, DOI: 10.1093/jac/39.suppl_2.35.Peer-Reviewed Original ResearchConceptsActivity of trovafloxacinCombination of trovafloxacinAmpicillin/sulbactamMicrodilution broth methodBroth methodCombination of ciprofloxacinEnterococcus faecium isolatesGram-negative organismsGram-positive organismsAntibiotic combinationsEnterococcus faecalis isolatesActive agentsFaecium isolatesTrovafloxacinComparison of MICsIndifferent effectStandard microdilution broth methodFaecalis isolatesGentamicinMorganella morganiiCiprofloxacinProteus mirabilisEtestSulbactamStenotrophomonas maltophilia
1996
Control of endemic glycopeptide-resistant enterococci.
Dembry LM, Uzokwe K, Zervos MJ. Control of endemic glycopeptide-resistant enterococci. Infection Control And Hospital Epidemiology 1996, 17: 286-92. PMID: 8727617, DOI: 10.1086/647297.Peer-Reviewed Original ResearchConceptsVancomycin-resistant EnterococcusRenal unitsEradication of carriageVRE stool colonizationCommunity teaching hospitalPatient carriageBarrier precautionsOral doxycyclineFurther patientsStool colonizationGlycopeptide-resistant enterococciCulture surveyTeaching hospitalPatientsStudy periodEnterococcus faeciumEnterococcus gallinarumCarriageRifampinDoxycyclineEnterococcusControl measuresDaysUseful measureHospitalComparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci
Weinstein JW, Tallapragada S, Farrel P, Dembry LM. Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci. Journal Of Clinical Microbiology 1996, 34: 210-212. PMID: 8748308, PMCID: PMC228765, DOI: 10.1128/jcm.34.1.210-212.1996.Peer-Reviewed Original Research